-
Neticonazole Hydrochloride: From Skin to Colon
2026-08-19
Neticonazole Hydrochloride is an imidazole antifungal with applications spanning cutaneous mycoses and exploratory colorectal cancer research. This article provides an evidence-aware framework for separating fungal membrane assays, exosome studies, apoptosis readouts, and colon-targeted delivery decisions.
-
VX-702: Practical p38α MAPK Assay Workflows
2026-08-19
VX-702 combines potent, selective p38α MAPK inhibition with a workflow-friendly profile for cytokine, platelet, arthritis, and ischemia-reperfusion studies. This guide translates kinase-mechanism findings into practical dosing, controls, readouts, and troubleshooting strategies without confusing biochemical potency with cellular response.
-
Cardiogreen (Indocyanine Green) Lab Guide
2026-08-18
A scenario-driven guide to using Cardiogreen (Indocyanine Green), SKU B8315, in cell viability, proliferation, cytotoxicity, and photodynamic workflows. It connects formulation, optical controls, protocol design, and interpretation with practical evidence and cited literature.
-
Dasatinib (BMS-354825) for Cancer Signaling
2026-08-18
Dasatinib (BMS-354825) provides a practical way to interrogate Src and Bcr-Abl signaling across phosphorylation, migration, EMT, and metastasis assays. This workflow connects validated prostate and PDAC model observations with hypothesis-driven studies of the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors.
-
Tacrine hydrochloride hydrate in AD Assays
2026-08-17
Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, connects quantitative cholinesterase inhibition with cell-based neuroprotection workflows. This guide shows how to use it as a mechanistic benchmark, troubleshoot assay artifacts, and evaluate tacrine-based designs without confusing cholinergic activity with general cytotoxicity.
-
EdU Imaging Kits (Cy5) in Pulmonary Hypertension
2026-08-17
A mechanistic and translational guide to using EdU-based S-phase measurements to connect hypoxia-driven endothelial proliferation with the HIF1α–PRDX1–DRP1 axis in pulmonary vascular remodeling.
-
Resveratrol Workflows for SIRT1 Neuroprotection
2026-08-16
Build a mechanism-resolved Resveratrol neuroprotection workflow around SIRT1, mitochondrial biogenesis, and apoptosis rather than relying on a single viability endpoint. This guide connects N2a-cell assay design with practical formulation, dose selection, controls, and troubleshooting for more reproducible translational studies.
-
Obeticholic Acid: A Mechanism-First Assay Strategy
2026-08-15
Obeticholic Acid is a selective FXR agonist for dissecting bile acid regulation, fibrotic signaling, and hepatic inflammation. This mechanism-first guide connects FXR assays with insights from 2025 11β-HSD1 fibrosis research to improve experimental decision-making.
-
Dimetridazole Workflows for Antimicrobial Research
2026-08-14
Dimetridazole supports more than endpoint growth inhibition: it can connect bacterial culture assay design with quorum sensing, biofilm, combination, infection model, and electrochemical workflows. This practical guide translates mechanistic and degradation evidence into controlled assay choices, quantitative starting conditions, and troubleshooting safeguards.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-08-14
A 2024 Advanced Science study identifies Kupffer-cell TMEM16F, rather than lymphocyte-expressed TMEM16F, as a key determinant of protection against Listeria monocytogenes. Its findings connect calcium-activated lipid scrambling and plasma-membrane repair with control of liver injury, inflammation, and metabolic disruption.
-
Hoechst 33342/PI Double Staining Kit for RCC
2026-08-13
Build a practical RCC treatment-response workflow around dual readouts of chromatin condensation and membrane damage. This guide shows how to apply the Hoechst 33342/PI Double Staining Kit to syringin–sunitinib studies, quantify three cell-state patterns, and troubleshoot misleading fluorescence.
-
EdU Imaging Kits for RCC Drug-Response Studies
2026-08-13
EdU Imaging Kits (HF488) convert S-phase DNA synthesis into a direct, quantitative readout for evaluating syringin, sunitinib, and combination responses in renal cell carcinoma models. Their antibody-free click-chemistry workflow supports both fluorescence imaging and flow cytometry while preserving cell morphology and antigen-accessible epitopes.
-
FPH1 (BRD-6125) Hepatocyte Workflow Guide
2026-08-12
FPH1 (BRD-6125) supports practical expansion and functional qualification of primary human hepatocytes and iPSC-derived hepatocyte-like cells. This workflow-focused guide combines proliferation, albumin, CYP3A4, and AFP readouts with solvent control, timing, and troubleshooting strategies for more reproducible assays.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-08-12
A 2026 study identified a novel pathogenic FLCN nonsense variant and provided functional evidence that the previously uncertain p.W376R variant is pathogenic in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored FLCN expression and reduced abnormal mTORC1 activation, offering an early, in vitro proof of concept for mRNA-based protein replacement in BHD syndrome.
-
DAPI Nuclear Stain Solution Protocol
2026-08-11
DAPI nuclear stain solution K2402 provides a ready-to-use fluorescent DNA stain for nuclear visualization and endpoint cell viability assessment. It is suited to fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, but its weak cell permeability makes it unsuitable as a primary live-cell imaging stain.